Outset Medical (NASDAQ:OM) reported quarterly losses of $(0.84) per share which beat the analyst consensus estimate of $(0.98) by 14.55 percent. This is a 88.09 percent increase over losses of $(7.05) per share from the same period last year. The company reported quarterly sales of $31.40 million which beat the analyst consensus estimate of $29.30 million by 7.17 percent. This is a 14.65 percent increase over sales of $27.39 million the same period last year.